FDMT Q3'26 Earnings Preview: Revenue Estimate
4D Molecular Therapeutics is scheduled to report Q3'26 results on November 11. The report time is not specified.
FDMT (4D Molecular Therapeutics, Inc.) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 4.13 million USD with EPS (earnings per share) anticipated at (1.05) USD. Learn more…